Alström syndrome (Q61769): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 09:15, 14 August 2026
Alstr om syndrome is a multisystemic disorder characterised by cone-rod dystrophy, hearing loss, obesity, insulin resistance and hyperinsulinemia, type 2 diabetes mellitus, dilated cardiomyopathy (DCM), and progressive hepatic and renal dysfunction.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_325733255 |
||
| English | Alström syndrome |
Alstr om syndrome is a multisystemic disorder characterised by cone-rod dystrophy, hearing loss, obesity, insulin resistance and hyperinsulinemia, type 2 diabetes mellitus, dilated cardiomyopathy (DCM), and progressive hepatic and renal dysfunction. |
Statements
CID11:ID_325733255
0 references
dki-india-ID_325733255
0 references
Concluído
0 references
13 August 2026
0 references
